Health, Fitness & Food

Halfpoint Images | Moment | Getty Images It’s open enrollment season, the time each year when millions of American workers and retirees must choose a health plan, whether new or existing. But picking health insurance can be a dizzying venture. Health plans have many moving parts — which may not come into focus at first

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Thursday’s key moments. It’s not too late to sell Quick mentions: QCOM, COST, HUM 1. It’s not too late to sell Stocks fell on Thursday, continuing Wednesday’s losses after the Federal Reserve reaffirmed

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT A health worker administers a dose of Pfizer covid-19 vaccine to a man at the Sanford Civic Center. With the emergence of the Omicron covid-19 variant in numerous countries, including the United States, the US Centers for Disease Control (CDC) encouraged all vaccinated adults to

Estee Lauder (EL) and other Club holdings with meaningful exposure to the Chinese economy bounced Friday, following news that BioNTech ‘s (BNTX) Covid vaccine will soon be available to foreign residents living in China. We’re cautiously optimistic about the vaccine development , which adds to hopes that Beijing will soften its restrictive pandemic policies after

A nurse administers a flu vaccination shot to a woman at a free clinic held at a local library on October 14, 2020 in Lakewood, California. Mario Tama | Getty Images The U.S. is facing the highest flu hospitalization rates in more than a decade with children and the elderly most at risk, according to

Dr. Anthony Fauci, White House Chief Medical Advisor and Director of the NIAID, responds to questions from Sen. Rand Paul (R-KY) at a Senate Health, Education, Labor, and Pensions Committee hearing on Capitol Hill on January 11, 2022 in Washington, D.C. Greg Nash | Pool | Getty Images White House chief medical advisor Dr. Anthony

Four of our Club holdings — Costco Wholesale (COST), Amazon (AMZN), Humana (HUM) and Bausch Health (BHC) — were in the news Thursday. Here’s how we feel about the developments. Costco The news: Costco reported sales for the retail month of October after the closing bell Wednesday evening. In the four-week period, net sales increased 7.7%

A vial of the Moderna coronavirus disease (COVID-19) booster vaccine targeting BA.4 and BA.5 Omicron sub variants is pictured at Skippack Pharmacy in Schwenksville, Pennsylvania, September 8, 2022. Hannah Beier | Reuters Moderna on Thursday lowered its 2022 sales guidance for its Covid-19 vaccine after missing Wall Street expectations for the third quarter. The Boston

Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding estimates of $6.28 per share. Aiding

Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla laid out his plan Tuesday

Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our

In this article PFE Follow your favorite stocksCREATE FREE ACCOUNT Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that

A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long

There are more than 100,000 people in the United States waiting for an organ transplant, according to the United Network for Organ Sharing, known as UNOS. “I was born Type 1 diabetic,” said Patrick McGlone, who received a dual kidney-pancreas transplant in June 2021. “There was always the word transplant thrown around. But I never

Medical staff treat a coronavirus disease (COVID-19) patient on the Intensive Care Unit (ICU) at the Cleveland Clinic in Cleveland, Ohio, January 7, 2022. Shannon Stapleton | Reuters Emerging omicron subvariants are resistant to key antibody treatments for HIV patients, kidney transplant recipients and other immunocompromised people, making them particularly vulnerable to Covid this winter,

We’re exiting our position in AbbVie (ABBV), selling 300 shares at roughly $148.14 each. We’re also buying 75 shares of Starbucks (SBUX) at roughly $85.93 each. Following Friday’s trades, Jim’s Charitable Trust will no longer own a position in AbbVie and will own 750 shares of Starbucks, increasing its weighting in the portfolio to 2.28%

AbbVie (ABBV) reported a mixed second-quarter Friday morning. Despite a pullback in shares after the release, we decided to lock-in a great 61% return and exit a stock that has been one of this year’s winners. We never like to sell on a down day, but multiple quarters in a row of revenue misses raised our

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The recently authorized booster vaccine protects against the original SARS-CoV-2 virus and the more recent omicron variants, BA.4 and BA.5. Scott Olson |

A rendering of COVID-19 new Omicron sub-variant BQ.1.1 Koto_feja | E+ | Getty Images Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S.,

Covid cases and controls have increased in China this month. Pictured here on Oct. 27, 2022, is a neighborhood in Shanghai that’s been fenced in for Covid control. Future Publishing | Future Publishing | Getty Images BEIJING — Covid controls in China have tightened in the last two weeks after more cities reported virus outbreaks.